Friday, 5 August 2016

Google Teams Up With GSK To Make Bioelectronics

By 2023, we just might be saying good-bye to our pills and traditional forms of treatment as GlaxoSmithKline (GSK) and Google's Alphabet life sciences unit are set to revolutionize medicine with a new form of treatment called Bioelectronics.

With Bioelectronics, disease will be treated by small implantable devices that can modify electrical nerve signals. The aim is to modulate irregular or altered impulses that occur in many illnesses.

A GSK representative, Famm said the first generation of implants coming to market would be around the size of a medical pill but the aim eventually was to make them as small or smaller than a grain of rice, using the latest advances in nanotechnology.

GSK believes chronic conditions such as diabetes, arthritis and asthma could be treated using these tiny devices, which consist of a electronic collar that wraps around nerves.

GSK and Google together will contribute 540 million pounds ($715 million) over seven years (2023) to Galvani Bioelectronics, they said on Monday.

Instagram: @healththenmore
Twitter: @healththenmore
YouTube Channel: Health Then More

No comments:

Post a Comment

Cord blood: The blood "miracle"

Did you know how important cord blood is? I'm guessing no but in the next couple of years, it will be much more popular than it is no...